Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-22

Clinical Trial Update: Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiation therapy followed by carmustine for supratentorial glioblastoma multiforme; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carmustine (carmustine)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED